Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SUPN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
SUPN
Supernus Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
SUPN
Supernus Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
SUPN
with
LLY
Uncorrelated: r 0.14 · 500D.
No shared co-movers.
SUPN, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
SUPN
Supernus Pharmaceuticals, Inc.
Change
26.76
▼
−5.13%
· post 26.90
Mkt cap
$3.2B
Revenue
$356M
Q3 FY26
Revenue
$719M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Closed
Nov 5 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
SUPN
Supernus Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
26.76
▼
−5.13%
post 26.90
Price
1,371.32
▼
−3.29%
post 1,363.77
$3.2B
Mkt cap
$1.3T
Q3 FY26
$356M
Revenue
$24.4B
Q3 FY26
FY25
$719M
Revenue
$65.2B
FY25
Change
Change
SUPN
26.76
▼
−5.13%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26